← Leaderboards
Charles Yen Chiu
University Of California, San Francisco
$12,010,203
Attributed
$18,538,129
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2008–23$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$18,538,129 · 9
By mechanism
R01$8,397,442 · 2
R33$4,790,784 · 2
R61$3,214,599 · 1
R56$888,279 · 1
R21$871,750 · 2
K08$375,275 · 1
Top collaborators
- Roberta Lynn Debiasi5 shared
- Iwijn De Vlaminck5 shared
- Christina Allen Rostad5 shared
- Adam R. Abate4 shared
- Jean L Patterson1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Krista Lyn Harrison$2,317,561
- Jeremy David Keenan$19,787,326
- Anand Dhruva$3,590,675
- Laura Fejerman$6,376,255
- Lisa Michelle Butler$6,602,136
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingDiagnosticTechnologyRespiratoryPathogenInfectionAcuteDetectionDiagnosisBaseCharacteristicsPlasmaPathogen DetectionVirusLaboratoriesSensitivity And SpecificityGenomeFeverViralCaliforniaCollaborationsDisease OutbreaksSymptomsWhole Blood
Grant awards (29)
Discovery and clinical validation of host biomarkers of disease severity and multi-system inflammatory syndrome in children (MIS-C) with Covid-19$1,619,520
R33 · FY2023 · HD · contact PI
Discovery and clinical validation of host biomarkers of disease severity and multi-system inflammatory syndrome in children (MIS-C) with Covid-19$1,606,346
R33 · FY2023 · HD · contact PI
Uncovering associations of variant infection with COVID-19 disease severity in children$1,541,111
R61 · FY2022 · HD · contact PI
Discovery and clinical validation of host biomarkers of disease severity and multi-system inflammatory syndrome in children (MIS-C) with Covid-19$809,678
R61 · FY2022 · HD · contact PI
Gigapixel digital PCR in Giant Unilamellar Vesicles$619,168
R01 · FY2022 · EB
Discovery and clinical validation of host biomarkers of disease severity and multi-system inflammatory syndrome in children (MIS-C) with Covid-19$863,810
R61 · FY2021 · HD · contact PI
Gigapixel digital PCR in Giant Unilamellar Vesicles$621,029
R01 · FY2021 · EB
Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious Agents$744,018
R01 · FY2020 · HL · contact PI
Gigapixel digital PCR in Giant Unilamellar Vesicles$627,044
R01 · FY2020 · EB
Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore Sequencing$482,750
R33 · FY2020 · AI · contact PI
Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious Agents$759,408
R01 · FY2019 · HL · contact PI
Gigapixel digital PCR in Giant Unilamellar Vesicles$639,634
R01 · FY2019 · EB
Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore Sequencing$577,816
R33 · FY2019 · AI · contact PI
Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious Agents$775,499
R01 · FY2018 · HL · contact PI
Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore Sequencing$504,352
R33 · FY2018 · AI · contact PI
Identification of diagnostic and prognostic host biomarkers of Zika virus infection by transcriptome profiling$237,750
R21 · FY2018 · AI · contact PI
Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious Agents$733,979
R01 · FY2017 · HL · contact PI
Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore Sequencing$237,750
R21 · FY2017 · AI · contact PI
Identification of diagnostic and prognostic host biomarkers of Zika virus infection by transcriptome profiling$198,125
R21 · FY2017 · AI · contact PI
Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore Sequencing$198,125
R21 · FY2016 · AI · contact PI
Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing$573,600
R01 · FY2015 · HL · contact PI
Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing$570,689
R01 · FY2014 · HL · contact PI
Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing$554,384
R01 · FY2013 · HL · contact PI
Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing$582,335
R01 · FY2012 · HL · contact PI
Broad Detection of Infectious Agents in Blood by Microarrays and Deep Sequencing$596,655
R01 · FY2011 · HL · contact PI
A Rapid Pan-Viral Microarray Diagnostic for Category A-C Biodefense Pathogens$888,279
R56 · FY2010 · AI · contact PI
Virus Detection Using Microarrays and Characterization of a Novel Cardiovirus$125,820
K08 · FY2010 · AI · contact PI
Virus Detection Using Microarrays and Characterization of a Novel Cardiovirus$125,415
K08 · FY2009 · AI · contact PI
Virus Detection Using Microarrays and Characterization of a Novel Cardiovirus$124,040
K08 · FY2008 · AI · contact PI